Dynamic immune signatures as biomarkers for irAEs. Academic Article

abstract

• Identifying predictive biomarkers of immune-related adverse events (irAEs) is crucial to maximize the benefits for patients with cancer treated with immune checkpoint inhibitors (ICIs). In a recent study published in Med,Nuez et al. utilized multi-omics approaches and identified blood immune signatures that have the potential to predict the development of autoimmune toxicity.

authors

• Han, Leng

published proceedings

• Trends Cancer

altmetric score

• 4.85

author list (cited authors)

• Yang, J., Chen, Y., & Han, L.

citation count

• 0

complete list of authors

• Yang, Jingwen||Chen, Yamei||Han, Leng

publication date

• May 2023

publisher

• Elsevier  Publisher

published in

• n2405-8025ISSN  Journal

keywords

• Biomarkers
• Humans
• Immune Checkpoint Inhibitors
• Immunotherapy
• Neoplasms

PubMed Central ID

• 36941187

Digital Object Identifier (DOI)

• 10.1016/j.trecan.2023.03.004

start page

• 379

end page

• 380

volume

• 9

issue

• 5

URL

• http://dx.doi.org/10.1016/j.trecan.2023.03.004